The FGFR alterations identified in CCA are mainly represented by fusions involving FGFR2, associated with various partners, the most frequent being BICC1 (nearly 30% of cases), found in 10–15% of iCCA [17,31,32,33,34]. The gene discussed is FGFR2; the disease is cholangiocarcinoma.